
Leading Hospital & Nursing Home Probiotics Function Markets Databank
Description
Leading Hospital & Nursing Home Probiotics Function Markets Databank
The Hospital & Nursing Home Probiotics market was valued at $1,600.0 Million in 2020, and is projected to reach $4,374.3 Million by 2029 growing at a CAGR of 11.87% from 2021 to 2029. Gut Health segment is expected to be the highest contributor to this market, with $669.1 Million in 2020, and is anticipated to reach $1,836.5 Million by 2029, registering a CAGR of 11.92%. Wellness segment is anticipated to reach $971.1 Million by 2029 with the highest CAGR of 12.06%. Gut Health and Immunity segments collectively expected to account for about 73.7% share of the Hospital & Nursing Home Probiotics market in 2020, with the former constituting around 41.8% share. Wellness and Immunity segments are expected to witness significant growth rates at a CAGR of 12.06% and 12.06% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 53.7% in the overall Hospital & Nursing Home Probiotics market in 2020, and is anticipated to reach 54.6% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
The Hospital & Nursing Home Probiotics market was valued at $1,600.0 Million in 2020, and is projected to reach $4,374.3 Million by 2029 growing at a CAGR of 11.87% from 2021 to 2029. Gut Health segment is expected to be the highest contributor to this market, with $669.1 Million in 2020, and is anticipated to reach $1,836.5 Million by 2029, registering a CAGR of 11.92%. Wellness segment is anticipated to reach $971.1 Million by 2029 with the highest CAGR of 12.06%. Gut Health and Immunity segments collectively expected to account for about 73.7% share of the Hospital & Nursing Home Probiotics market in 2020, with the former constituting around 41.8% share. Wellness and Immunity segments are expected to witness significant growth rates at a CAGR of 12.06% and 12.06% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 53.7% in the overall Hospital & Nursing Home Probiotics market in 2020, and is anticipated to reach 54.6% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
Table of Contents
80 Pages
- 1. GLOBAL HOSPITAL & NURSING HOME PROBIOTICS MARKET, BY FUNCTION
- 1.1. OVERVIEW
- 1.2. GUT HEALTH
- 1.2.1 GUT HEALTH MARKET, BY REGION
- 1.2.1.1 North America Gut Health Market, By Country
- 1.2.1.2 Europe Gut Health Market, By Country
- 1.2.1.3 Asia-Pacific Gut Health Market, By Country
- 1.2.1.4 Rest of World Gut Health Market, By Country
- 1.3. IMMUNITY
- 1.3.1 IMMUNITY MARKET, BY REGION
- 1.3.1.1 North America Immunity Market, By Country
- 1.3.1.2 Europe Immunity Market, By Country
- 1.3.1.3 Asia-Pacific Immunity Market, By Country
- 1.3.1.4 Rest of World Immunity Market, By Country
- 1.4. WELLNESS
- 1.4.1 WELLNESS MARKET, BY REGION
- 1.4.1.1 North America Wellness Market, By Country
- 1.4.1.2 Europe Wellness Market, By Country
- 1.4.1.3 Asia-Pacific Wellness Market, By Country
- 1.4.1.4 Rest of World Wellness Market, By Country
- 1.5. OTHER FUNCTIONS
- 1.5.1 OTHER FUNCTIONS MARKET, BY REGION
- 1.5.1.1 North America Other Functions Market, By Country
- 1.5.1.2 Europe Other Functions Market, By Country
- 1.5.1.3 Asia-Pacific Other Functions Market, By Country
- 1.5.1.4 Rest of World Other Functions Market, By Country
- TABLE 1. GLOBAL HOSPITAL & NURSING HOME PROBIOTICS MARKET VALUE, BY FUNCTION , 2020-2029, MILLION USD
- TABLE 2. GUT HEALTH MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 3. NORTH AMERICA GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 4. EUROPE GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 5. ASIA-PACIFIC GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 6. REST OF WORLD GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 7. IMMUNITY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 8. NORTH AMERICA IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 9. EUROPE IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 10. ASIA-PACIFIC IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 11. REST OF WORLD IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 12. WELLNESS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 13. NORTH AMERICA WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 14. EUROPE WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 15. ASIA-PACIFIC WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 16. REST OF WORLD WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 17. OTHER FUNCTIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 18. NORTH AMERICA OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 19. EUROPE OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 20. ASIA-PACIFIC OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 21. REST OF WORLD OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 1. GLOBAL HOSPITAL & NURSING HOME PROBIOTICS MARKET VALUE, BY FUNCTION , 2020-2029, MILLION USD
- FIGURE 2. GUT HEALTH MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 3. NORTH AMERICA GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 4. EUROPE GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 5. ASIA-PACIFIC GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 6. REST OF WORLD GUT HEALTH MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 7. IMMUNITY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 8. NORTH AMERICA IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 9. EUROPE IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 10. ASIA-PACIFIC IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 11. REST OF WORLD IMMUNITY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 12. WELLNESS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 13. NORTH AMERICA WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 14. EUROPE WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 15. ASIA-PACIFIC WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 16. REST OF WORLD WELLNESS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 17. OTHER FUNCTIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 18. NORTH AMERICA OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 19. EUROPE OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 20. ASIA-PACIFIC OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 21. REST OF WORLD OTHER FUNCTIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.